An update on thalassemia intermedia

The Spine in β-thalassemia syndromes

Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major

Effects of divalproex sodium on hemoglobin level

Clinicovirologic analysis of hepatitis C infection in transfusion-dependent β-thalassemia major children

Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: Uncovering yet another covert abnormality

Primary pure squamous cell carcinoma of the breast: A case report and review of the literature

Optimal management of β thalassaemia intermedia

Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo

Optimal management of β thalassaemia intermedia

Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia

Age-related complications in treatment-naïve patients with thalassaemia intermedia

Budd-Chiari syndrome with underlying homozygous factor V Leiden and heterozygous methylenetetrahydrofolate reductase mutations [4]

Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia

A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia

Carbamazepine-induced thrombocytopenia

Thromboembolism and toxic shock syndrome: A case presentation and literature update

Efficacy and safety of deferasirox at low and high iron burdens: Results from the EPIC magnetic resonance imaging substudy

Iron and hepatitis C: What can we learn from thalassemia major?

Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: A single institution experience from the American University of Beirut